Author

C. E. Hay

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:protein sequence· 1

Frequent Co-Authors

C. T. Bolden· 1 shared E. C. Peterson· 1 shared J. C. Small· 1 shared L. E. Ewing· 1 shared M. D. Hambuchen· 1 shared P. Margaritis· 1 shared S. M. Owens· 1 shared S. M. Zintner· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

C. T. Bolden

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivJun 29, 2019

The development and characterization of an scFv-Fc fusion based gene therapy to reduce the psychostimulant effects of methamphetamine abuse

C. E. Hay, L. E. Ewing, M. D. Hambuchen…·E. C. Peterson

This paper develops and tests an scFv-Fc fusion antibody gene therapy for reducing methamphetamine's psychostimulant effects in mice, showing dose-dependent efficacy in locomotor and biodistribution studies.

DOI 10.1124/jpet.119.261180

mouseprotein sequence

𝕏 PostBluesky